VIKING SCIENTIFIC, INC.

Profile

Company Names

VIKING SCIENTIFIC, INC.

Addresses

667 AVENIDA CORDOBA, SAN MARCOS, CA 92069

1637 CAPALINA ROAD, SAN MARCOS, CA 92069

Phone Numbers

619-416-9608

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

CALIFORNIA

Total Amount Raised:

$233,499.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-07-12 
$99,999.00 
$400,000.00 
$300,001.00 
Equity 
2
2020-09-15 
$113,500.00 
$228,572.00 
$115,072.00 
Equity 
1
2017-10-19 
$20,000.00 
$300,000.00 
$280,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
DEMPSEY 
EXECUTIVE OFFICER, DIRECTOR
VIKING SCIENTIFIC, INC.
JOE 
 
DEPINTO 
DIRECTOR
VIKING SCIENTIFIC, INC.
GREGORY 
 
FISHER 
EXECUTIVE OFFICER, DIRECTOR
ALAMOS GOLD INC   |  ALAMOS GOLD INC.   |  VIKING SCIENTIFIC, INC.
PAUL 
 
FISHER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TOWER OF BABEL, LLC   |  VIKING SCIENTIFIC, INC.   |  INTERLEUKIN COMBINATORIAL THERAPIES, INC.
GLENN 
 
MATTES 
DIRECTOR
ADVANTAGENE, INC.   |  CORNOVUS PHARMACEUTICALS INC.   |  VIKING SCIENTIFIC, INC.   |  TFF PHARMACEUTICALS, INC.
FRANK 
J. 
PAPATHEOFANIS 
DIRECTOR
VIKING SCIENTIFIC, INC.
JEFFREY 
 
PATTON 
DIRECTOR
RXREVU, INC.   |  VIKING SCIENTIFIC, INC.   |  ONEONCOLOGY MANAGEMENT HOLDCO, LLC   |  TULLAHOMA MEDICAL INVESTMENT LLC   |  MURFREESBORO MEDICAL INVESTMENT LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-07-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-12 
2020-11-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-15 
2017-12-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#